No noticeNo retraction, correction or concern found when last checked on Nov 7, 2026.

Structure-based drug designing and immunoinformatics approach for SARS-CoV-2

Pritam Kumar Panda, Murugan Natarajan Arul, Paritosh Patel and 6 more

Science Advances · 2020 · CC BY

doi:10.1126/sciadv.abb8097 (opens in a new tab)

Read free

We email you when a new notice or a question about this paper appears.

Abstract

We report development of in-silico approaches for the identification of anti-coronaviral drugs against SARS-CoV-2.

Abstract licence: CC BY

Cited by papers we hold2

The study of antiviral drugs targeting SARS-CoV-2 nucleocapsid and spike proteins through large-scale compound repurposing · 2021
Not checked
Graphene, Carbon Nanotube and Plasmonic Nanosensors for Detection of Viral Pathogens: Opportunities for Rapid Testing in Pandemics like COVID-19 · 2021
Not checked

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.